Abstract
Liver transplantation numbers in the United States remained constant from 2004 to 2007, while the number of waiting list candidates has trended down. In 2007, the waiting list was at its smallest since 1999, with adults > or =50 years representing the majority of candidates. Noncholestatic cirrhosis was most commonly diagnosed. Most age groups had decreased waiting list death rates; however, children <1 year had the highest death rate. Use of liver allografts from donation after cardiac death (DCD) donors increased in 2007. Model for end-stage liver disease (MELD)/pediatric model for end-stage liver disease (PELD) scores have changed very little since 2002, with MELD/PELD <15 accounting for 75% of the waiting list. Over the same period, the number of transplants for MELD/PELD <15 decreased from 16.4% to 9.8%. Hepatocellular carcinoma exceptions increased slightly. The intestine transplantation waiting list decreased from 2006, with the majority of candidates being children <5 years old. Death rates improved, but remain unacceptably high. Policy changes have been implemented to improve allocation and recovery of intestine grafts to positively impact mortality. In addition to evaluating trends in liver and intestine transplantation, we review in depth, issues related to organ acceptance rates, DCD, living donor transplantation and MELD/PELD exceptions.
Highlights
Introduction bThe articles in this report are based on the reference tables in the 2008 Organ Procurement and Transplantation Network (OPTN)/SRTR Annual Report
In addition to evaluating trends in liver and intestine transplantation, we review in depth, issues related to organ acceptance rates, donation after cardiac death (DCD), living donor transplantation and Model for end-stage liver disease (MELD)/pediatric model for end-stage liver disease (PELD) exceptions
In addition to reviewing trends in the waiting list, deceased and living donor transplant recipients and posttransplant outcomes, special sections are included on issues related to organ acceptance rates, donation after cardiac death (DCD), living donor transplantation and MELD/PELD exceptions
Summary
V. Mazariegosh a University of Virginia, Charlottesville, VA
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.